• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2Y 嘌呤能受体、内皮功能障碍与心血管疾病。

P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

机构信息

The Department of Medicine Cardiovascular and Pulmonary Research Laboratory, University of Colorado Denver, Aurora, CO 80045, USA.

Vascular Biology Center, Augusta University, Augusta, GA 30912, USA.

出版信息

Int J Mol Sci. 2020 Sep 18;21(18):6855. doi: 10.3390/ijms21186855.

DOI:10.3390/ijms21186855
PMID:32962005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7555413/
Abstract

Purinergic G-protein-coupled receptors are ancient and the most abundant group of G-protein-coupled receptors (GPCRs). The wide distribution of purinergic receptors in the cardiovascular system, together with the expression of multiple receptor subtypes in endothelial cells (ECs) and other vascular cells demonstrates the physiological importance of the purinergic signaling system in the regulation of the cardiovascular system. This review discusses the contribution of purinergic P2Y receptors to endothelial dysfunction (ED) in numerous cardiovascular diseases (CVDs). Endothelial dysfunction can be defined as a shift from a "calm" or non-activated state, characterized by low permeability, anti-thrombotic, and anti-inflammatory properties, to a "activated" state, characterized by vasoconstriction and increased permeability, pro-thrombotic, and pro-inflammatory properties. This state of ED is observed in many diseases, including atherosclerosis, diabetes, hypertension, metabolic syndrome, sepsis, and pulmonary hypertension. Herein, we review the recent advances in P2Y receptor physiology and emphasize some of their unique signaling features in pulmonary endothelial cells.

摘要

嘌呤能 G 蛋白偶联受体是古老的,也是最丰富的 G 蛋白偶联受体 (GPCR) 家族之一。嘌呤能受体在心血管系统中的广泛分布,以及多种受体亚型在内皮细胞 (ECs) 和其他血管细胞中的表达,表明嘌呤能信号系统在心血管系统调节中的生理重要性。本综述讨论了嘌呤能 P2Y 受体在多种心血管疾病 (CVDs) 中对内皮功能障碍 (ED) 的贡献。内皮功能障碍可定义为从“平静”或非激活状态向“激活”状态的转变,其特征为低通透性、抗血栓和抗炎特性,“激活”状态的特征为血管收缩和通透性增加、促血栓形成和促炎特性。这种 ED 状态可见于许多疾病,包括动脉粥样硬化、糖尿病、高血压、代谢综合征、败血症和肺动脉高压。在此,我们综述了 P2Y 受体生理学的最新进展,并强调了它们在内皮细胞中的一些独特信号特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/1da42034ee7a/ijms-21-06855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/e21b42fe6d1a/ijms-21-06855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/374ca9a5049b/ijms-21-06855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/8d4b77d4bcf0/ijms-21-06855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/b5cc4bb09331/ijms-21-06855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/8896a11f89e0/ijms-21-06855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/1da42034ee7a/ijms-21-06855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/e21b42fe6d1a/ijms-21-06855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/374ca9a5049b/ijms-21-06855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/8d4b77d4bcf0/ijms-21-06855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/b5cc4bb09331/ijms-21-06855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/8896a11f89e0/ijms-21-06855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4576/7555413/1da42034ee7a/ijms-21-06855-g006.jpg

相似文献

1
P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.P2Y 嘌呤能受体、内皮功能障碍与心血管疾病。
Int J Mol Sci. 2020 Sep 18;21(18):6855. doi: 10.3390/ijms21186855.
2
The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.内皮 P2Y 受体在心血管健康中的相互作用:从血管生理学到病理学。
Int J Mol Sci. 2022 May 24;23(11):5883. doi: 10.3390/ijms23115883.
3
P2X and P2Y nucleotide receptors as targets in cardiovascular disease.P2X 和 P2Y 核苷酸受体作为心血管疾病的靶点。
Future Med Chem. 2013 Mar;5(4):431-49. doi: 10.4155/fmc.13.6.
4
Control of Macrophage Inflammation by P2Y Purinergic Receptors.P2Y 嘌呤能受体对巨噬细胞炎症的控制。
Cells. 2021 May 4;10(5):1098. doi: 10.3390/cells10051098.
5
c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.c-Jun、Foxo3a 和 c-Myc 转录因子是肺血管腔内皮细胞中 ATP 介导的血管生成反应的关键调节因子。
Cells. 2020 Feb 11;9(2):416. doi: 10.3390/cells9020416.
6
Pharmacology of P2Y receptors.P2Y 受体的药理学。
Brain Res Bull. 2019 Sep;151:12-24. doi: 10.1016/j.brainresbull.2019.03.010. Epub 2019 Mar 25.
7
Pharmacology and structure of P2Y receptors.P2Y受体的药理学与结构
Neuropharmacology. 2016 May;104:50-61. doi: 10.1016/j.neuropharm.2015.10.030. Epub 2015 Oct 28.
8
Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases.嘌呤能 P2Y 受体:分子多样性及其对心血管疾病治疗的意义。
Pharmacol Ther. 2017 Dec;180:113-128. doi: 10.1016/j.pharmthera.2017.06.010. Epub 2017 Jun 23.
9
Purinergic Signaling in the Cardiovascular System.嘌呤能信号在心血管系统中的作用。
Circ Res. 2017 Jan 6;120(1):207-228. doi: 10.1161/CIRCRESAHA.116.309726.
10
Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells.通过P2Y受体的嘌呤能信号传导上调肝脏巨噬细胞/库普弗细胞产生白细胞介素-6。
J Toxicol Sci. 2014 Jun;39(3):413-23. doi: 10.2131/jts.39.413.

引用本文的文献

1
Molecular Mediated Angiogenesis and Vasculogenesis Networks.分子介导的血管生成和血管发生网络
Int J Mol Sci. 2025 Jun 30;26(13):6316. doi: 10.3390/ijms26136316.
2
Single-cell RNA sequencing: new insights for pulmonary endothelial cells.单细胞RNA测序:肺内皮细胞的新见解
Front Cell Dev Biol. 2025 Jun 17;13:1576067. doi: 10.3389/fcell.2025.1576067. eCollection 2025.
3
Unveiling the Interplay: Neurovascular Coupling, Astrocytes and G Protein-Coupled Receptors in Alzheimer's Disease.揭示相互作用:阿尔茨海默病中的神经血管耦合、星形胶质细胞和G蛋白偶联受体

本文引用的文献

1
P2 Purinergic Signaling in the Distal Lung in Health and Disease.嘌呤能信号在远端肺部的健康和疾病中的作用。
Int J Mol Sci. 2020 Jul 14;21(14):4973. doi: 10.3390/ijms21144973.
2
Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.细胞外腺苷通过 Gi/ELMO1/Rac1/PKA 依赖性信号通路增强肺动脉小血管内皮细胞屏障功能。
Am J Physiol Cell Physiol. 2020 Jul 1;319(1):C183-C193. doi: 10.1152/ajpcell.00505.2019. Epub 2020 May 20.
3
Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium.
ACS Pharmacol Transl Sci. 2025 Jan 8;8(2):271-285. doi: 10.1021/acsptsci.4c00614. eCollection 2025 Feb 14.
4
Extracellular purines in lung endothelial permeability and pulmonary diseases.细胞外嘌呤与肺内皮通透性及肺部疾病
Front Physiol. 2024 Aug 20;15:1450673. doi: 10.3389/fphys.2024.1450673. eCollection 2024.
5
Functionalized Congeners of 2-Chromene P2Y Receptor Antagonists.2-色烯 P2Y 受体拮抗剂的功能化同系物。
Cells. 2024 Aug 16;13(16):1366. doi: 10.3390/cells13161366.
6
How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.选择性拮抗剂和基因改造如何有助于表征血管P2Y受体的表达和功能。
Purinergic Signal. 2025 Feb;21(1):11-22. doi: 10.1007/s11302-024-10016-z. Epub 2024 May 13.
7
Cutaneous melanoma and purinergic modulation by phenolic compounds.皮肤黑色素瘤和酚类化合物的嘌呤能调制。
Purinergic Signal. 2024 Dec;20(6):581-593. doi: 10.1007/s11302-024-10002-5. Epub 2024 Mar 18.
8
P2Y-P2X7 receptors cross-talk in primed mesenteric endothelial cells upregulates NF-κB signaling favoring mononuclear cell adhesion in schistosomiasis.P2Y-P2X7 受体在致敏肠系膜内皮细胞中的串扰上调 NF-κB 信号通路,有利于血吸虫病中单核细胞的黏附。
Front Immunol. 2024 Jan 4;14:1328897. doi: 10.3389/fimmu.2023.1328897. eCollection 2023.
9
Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats.参与ADPβS引起大鼠血压变化的嘌呤能P2Y受体亚型的药理学特性
Pharmaceuticals (Basel). 2023 Dec 3;16(12):1683. doi: 10.3390/ph16121683.
10
Purinergic signaling in the battlefield of viral infections.病毒感染战场中的嘌呤能信号传导
Purinergic Signal. 2025 Feb;21(1):83-98. doi: 10.1007/s11302-023-09981-8. Epub 2023 Dec 1.
内皮细胞 Pannexin 1 通道通过调节细胞内钙控制炎症。
J Immunol. 2020 Jun 1;204(11):2995-3007. doi: 10.4049/jimmunol.1901089. Epub 2020 Apr 20.
4
Negative Regulation of TNFR1 Signaling Via PKA-Mediated Phosphorylation of TNFR1.通过 PKA 介导的 TNFR1 磷酸化负调控 TNFR1 信号。
J Interferon Cytokine Res. 2020 May;40(5):225-235. doi: 10.1089/jir.2019.0128. Epub 2020 Mar 10.
5
Modulation of P2Y11-related purinergic signaling in inflammation and cardio-metabolic diseases.P2Y11 相关嘌呤能信号在炎症和心代谢疾病中的调节作用。
Eur J Pharmacol. 2020 Jun 5;876:173060. doi: 10.1016/j.ejphar.2020.173060. Epub 2020 Mar 4.
6
Alteration of purinergic signaling in diabetes: Focus on vascular function.糖尿病中嘌呤能信号的改变:关注血管功能。
J Mol Cell Cardiol. 2020 Mar;140:1-9. doi: 10.1016/j.yjmcc.2020.02.004. Epub 2020 Feb 11.
7
c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.c-Jun、Foxo3a 和 c-Myc 转录因子是肺血管腔内皮细胞中 ATP 介导的血管生成反应的关键调节因子。
Cells. 2020 Feb 11;9(2):416. doi: 10.3390/cells9020416.
8
Update of P2Y receptor pharmacology: IUPHAR Review 27.P2Y受体药理学更新:IUPHAR综述27
Br J Pharmacol. 2020 Jun;177(11):2413-2433. doi: 10.1111/bph.15005. Epub 2020 Apr 6.
9
Agonism of GPR120 prevents ox-LDL-induced attachment of monocytes to endothelial cells.激动 GPR120 可防止 ox-LDL 诱导的单核细胞附着在内皮细胞上。
Chem Biol Interact. 2020 Jan 25;316:108916. doi: 10.1016/j.cbi.2019.108916. Epub 2019 Dec 21.
10
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation.穿越血管屏障:控制血管外渗的内皮信号转导过程。
Physiol Rev. 2019 Jul 1;99(3):1467-1525. doi: 10.1152/physrev.00037.2018.